ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Headache,Headaches NEC,Headaches,Nerv,N
3,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
6,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
7,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
7,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
11,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
14,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
14,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
14,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
15,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
16,1,Benign breast neoplasm,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
17,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
17,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
19,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
20,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
21,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
22,1,Migraine,Migraine headaches,Headaches,Nerv,N
23,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
24,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
25,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
26,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
27,1,Contact lens intolerance,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
28,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
29,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
30,1,Mucocutaneous ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
31,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
32,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
32,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
32,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
33,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
33,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
35,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
36,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
37,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
38,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
39,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
40,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
40,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
41,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
41,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
41,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
42,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
43,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
44,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
45,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
46,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,3,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
46,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
47,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
48,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
48,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
50,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
51,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
51,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
51,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
51,5,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
52,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
54,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
54,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
54,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
55,1,Headache,Headaches NEC,Headaches,Nerv,N
55,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
56,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
57,1,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
57,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
58,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
59,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
60,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
60,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
61,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
62,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
64,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
64,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
65,1,Blood lactate dehydrogenase,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
65,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
66,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
67,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
67,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
67,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
68,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
69,1,Headache,Headaches NEC,Headaches,Nerv,N
69,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
69,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
69,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
70,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
70,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
71,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
71,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
72,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
73,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
73,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
73,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
75,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
76,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
78,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
79,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
79,3,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
80,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
80,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
82,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
82,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
82,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
83,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
83,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
85,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
86,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
86,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
87,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
88,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
89,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
90,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
91,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
91,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
91,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
91,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
92,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
92,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
93,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,1,Headache,Headaches NEC,Headaches,Nerv,N
95,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
96,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
97,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
98,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
99,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
101,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
102,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
103,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
103,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
104,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
104,2,Mesenteric lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
105,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
106,1,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
107,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
108,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
109,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
110,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
110,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
111,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
112,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
112,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
112,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
112,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
113,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
114,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
114,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
114,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
114,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
116,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
116,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
116,3,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
116,4,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
117,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
117,2,Headache,Headaches NEC,Headaches,Nerv,N
117,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
118,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
118,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
118,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
118,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
118,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
118,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
119,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
120,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
120,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Deafness,Hearing losses,Hearing disorders,Ear,N
121,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
122,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
123,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
124,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
125,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
126,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
126,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
127,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
128,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
128,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
128,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
128,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
128,5,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
129,1,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
130,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
131,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
132,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
132,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
134,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
134,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
134,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
134,5,Scrotal irritation,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
135,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
136,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
137,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
137,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
137,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
137,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
137,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
137,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
138,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
139,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
139,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
140,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
140,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
141,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
142,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
143,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
143,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
144,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
144,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
145,1,Injection site granuloma,Injection site reactions,Administration site reactions,Genrl,N
146,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
147,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
148,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
149,1,Abscess sterile,Inflammations,General system disorders NEC,Genrl,N
149,2,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
149,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
150,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
150,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
150,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
152,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
153,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
153,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
154,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
154,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
156,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,2,Blood chloride decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
156,3,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
157,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
158,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
159,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
159,2,Headache,Headaches NEC,Headaches,Nerv,N
159,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
159,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
160,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
161,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
162,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
162,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
163,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
163,2,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
164,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
164,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
165,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
165,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
167,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
168,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
168,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
169,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
169,2,Oestrogen deficiency,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
169,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
170,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
170,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
170,3,Headache,Headaches NEC,Headaches,Nerv,N
170,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
171,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
172,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
172,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
173,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
173,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
174,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
176,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
176,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
176,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
177,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
177,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
179,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
179,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
179,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
179,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
179,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
180,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,2,Penile haemorrhage,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
181,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
182,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
183,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
183,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
183,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
184,1,Sciatic nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
185,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
185,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
185,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
185,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
186,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
186,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
186,3,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
186,4,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
186,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
187,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
188,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
189,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
189,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
190,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
191,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
192,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
193,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
194,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
195,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
195,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
196,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
197,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
197,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
197,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
198,1,Sex chromosome abnormality,Sex chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
199,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
199,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
199,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
199,4,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
199,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
199,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
199,7,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
199,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
199,9,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
199,10,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
199,11,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
200,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
201,1,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
201,2,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
202,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
202,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
202,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
202,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
202,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
202,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
203,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
203,2,Injection site cyst,Injection site reactions,Administration site reactions,Genrl,N
204,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
205,1,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
205,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,3,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
205,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
205,5,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
205,6,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
205,7,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
206,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
207,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
208,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
208,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
208,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
209,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
209,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
209,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
210,1,Migraine,Migraine headaches,Headaches,Nerv,N
210,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
211,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
211,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
212,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
212,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
212,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
213,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
214,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
215,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
216,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
216,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
217,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
217,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
217,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
217,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
218,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
218,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
219,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
219,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
220,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
220,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
221,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
221,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
221,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
221,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
221,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
222,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
222,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
223,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
224,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
224,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
224,3,Sex chromosome abnormality,Sex chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
225,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
225,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
225,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
226,1,Y-linked chromosomal disorder,Sex chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
227,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
228,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
229,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
230,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
231,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
231,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
231,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
232,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
232,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
232,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
233,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
233,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
233,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
234,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
235,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
235,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
235,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
237,1,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
237,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
238,1,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
238,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
239,1,Headache,Headaches NEC,Headaches,Nerv,N
240,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
240,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
240,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
241,1,Injection site abscess sterile,Injection site reactions,Administration site reactions,Genrl,N
242,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
243,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
244,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
244,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
244,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
244,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
245,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
245,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
246,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
246,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
246,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
246,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
246,5,Headache,Headaches NEC,Headaches,Nerv,N
246,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
246,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
246,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
247,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
248,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
248,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
249,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
250,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
251,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
251,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
251,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
251,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
252,1,Injection site granuloma,Injection site reactions,Administration site reactions,Genrl,N
253,1,Injection site granuloma,Injection site reactions,Administration site reactions,Genrl,N
254,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
254,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
255,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
255,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
256,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
256,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
257,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
257,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
257,3,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
257,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
258,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
258,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
259,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
259,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
259,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
259,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
259,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
259,6,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
259,7,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
259,8,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
259,9,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
259,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
259,11,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
259,12,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
259,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
259,14,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
259,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
260,1,Testicular retraction,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
261,1,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
261,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
261,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
262,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
262,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
263,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
264,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
265,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
265,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
267,1,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
267,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
268,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
269,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
269,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
270,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
270,2,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
270,3,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
270,4,Gambling,Social issues NEC,Lifestyle issues,SocCi,N
270,5,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
270,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
270,7,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
270,8,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
270,9,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
271,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
272,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
272,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
273,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
273,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
273,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
273,4,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
274,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
275,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
276,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
277,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
277,2,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
277,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
277,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
277,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
277,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
277,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
278,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
278,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
279,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
279,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
280,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
281,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
281,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
281,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
282,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
282,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
282,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
283,1,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
284,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
284,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
284,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
285,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
286,1,Abscess bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
287,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
287,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
287,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
287,4,Infusion site irritation,Infusion site reactions,Administration site reactions,Genrl,N
287,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
287,6,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
287,7,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
288,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
289,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
290,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
290,2,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
290,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
290,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
291,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
291,2,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
292,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
293,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
293,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
293,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
293,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
294,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
294,2,Deja vu,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
294,3,Dissociation,Dissociative states,Dissociative disorders,Psych,N
294,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
295,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
295,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
295,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
296,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
296,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
296,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
297,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
297,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
297,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
297,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
297,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
297,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
297,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
297,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,9,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
298,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
298,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
298,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
299,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
300,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
300,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
301,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
301,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
302,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
302,2,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
303,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
303,2,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
303,3,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
303,4,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
303,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
304,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
304,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
304,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
304,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
304,6,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
305,1,Implant site reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
305,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
306,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
306,2,Focal nodular hyperplasia,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
307,1,Device issue,Device issues NEC,Device issues,Prod,N
307,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
307,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
307,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
307,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
307,6,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
308,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
308,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
308,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
308,4,Soft tissue disorder,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
309,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
309,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
310,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
310,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
311,1,Abdominal wall abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
312,1,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
313,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
313,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
314,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
314,2,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
314,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
315,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
315,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
315,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
315,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
315,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
315,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
315,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
315,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
316,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
316,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,Y
316,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
316,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
317,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
317,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
318,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
318,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
319,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
319,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
320,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
321,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
322,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
323,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
323,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
324,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
324,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
324,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
324,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
325,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
325,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
326,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
328,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
329,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
330,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
331,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
331,2,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
331,3,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
331,4,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
331,5,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
331,6,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
331,7,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
331,8,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
331,9,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,10,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
331,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
331,12,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
331,13,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
331,14,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
331,15,Headache,Headaches NEC,Headaches,Nerv,N
331,16,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
331,17,Idiopathic environmental intolerance,General signs and symptoms NEC,General system disorders NEC,Genrl,N
331,18,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
331,19,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
331,20,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
331,21,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
331,22,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
331,23,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
331,24,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
331,25,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,26,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
331,27,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
331,28,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
331,29,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
331,30,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
331,31,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
331,32,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
331,33,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
331,34,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
331,35,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
332,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
332,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
333,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
334,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
334,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
334,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
334,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
334,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
334,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
335,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
335,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
335,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
336,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
336,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
336,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
337,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
337,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
337,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
338,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
338,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
339,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
341,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
341,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
342,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
343,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
343,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
344,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
345,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
346,1,Abscess sterile,Inflammations,General system disorders NEC,Genrl,N
347,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
347,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
347,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
347,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
347,5,Myosclerosis,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
347,6,Wound necrosis,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
348,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
348,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
349,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
349,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
350,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
350,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
350,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
350,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
350,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
350,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
350,7,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
350,8,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
350,9,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
351,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
351,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
351,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
351,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
352,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
352,2,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
352,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
352,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
352,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
352,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
353,2,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
353,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
353,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
353,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
353,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
354,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
354,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
354,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
355,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
356,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
356,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
356,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
356,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
356,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
356,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
356,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
356,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
356,9,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
356,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
357,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
357,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
357,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
357,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
357,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
357,7,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
358,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,2,Erection increased,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
358,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
359,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
359,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
360,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
361,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
361,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
361,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
361,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
361,5,Headache,Headaches NEC,Headaches,Nerv,N
361,6,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
361,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
361,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
361,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
361,11,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
361,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
362,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
362,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
362,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
362,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
362,5,Headache,Headaches NEC,Headaches,Nerv,N
362,6,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
362,7,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
362,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
362,9,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
362,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
362,11,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
362,12,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
362,13,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
362,14,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
362,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
363,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
363,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
364,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
365,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
365,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
365,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
365,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
366,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
367,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
368,1,Penile size reduced,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
369,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
369,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
369,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
369,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
369,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
369,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
369,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
370,1,Hemiplegic migraine,Migraine headaches,Headaches,Nerv,N
371,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
371,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
371,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
371,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
372,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
372,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
373,1,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
374,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
374,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
374,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
375,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
375,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
376,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
376,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
376,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
376,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
376,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
376,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
376,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
376,8,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
376,9,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
376,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
376,11,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
376,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
376,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
376,14,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
376,15,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
376,16,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
377,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
377,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
377,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
378,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
378,2,Migraine,Migraine headaches,Headaches,Nerv,N
378,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
378,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
379,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
380,1,Blood immunoglobulin A decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
380,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
380,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
380,4,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
381,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
381,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
381,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
382,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
382,2,Device issue,Device issues NEC,Device issues,Prod,N
383,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
383,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
383,3,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
383,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
383,5,Product reconstitution quality issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
384,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
384,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
384,3,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
385,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
385,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
385,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
385,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
385,5,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
386,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
387,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
388,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
388,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
388,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
388,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
388,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
388,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
388,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
388,8,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
388,9,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
389,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
389,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
390,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
390,2,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
390,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
391,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
391,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
392,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
392,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
393,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
394,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
394,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
394,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
394,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
394,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
395,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
395,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
395,3,Headache,Headaches NEC,Headaches,Nerv,N
395,4,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
395,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
395,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
395,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
396,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
396,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
396,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
397,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
397,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
397,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
397,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
397,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
398,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
398,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
398,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
398,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
398,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
398,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
398,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
398,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
398,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
398,10,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
398,11,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
399,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
399,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
399,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
399,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
400,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
400,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
400,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
401,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
401,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
401,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
401,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
402,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
402,2,Cluster headache,Headaches NEC,Headaches,Nerv,N
402,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
402,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
402,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
402,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
402,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
403,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
403,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
404,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
404,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
404,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
405,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
405,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
406,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
406,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
406,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
406,4,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
407,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
407,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
407,3,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
407,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
408,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
408,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
408,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
408,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
409,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
410,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
410,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
410,3,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
411,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
411,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
411,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
411,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
411,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
412,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
412,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
412,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
413,1,Foreign body reaction,Inflammations,General system disorders NEC,Genrl,N
414,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
414,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
415,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
416,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
416,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
417,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
418,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
418,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
419,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
419,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
420,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
420,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
420,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
420,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
420,5,Premenstrual dysphoric disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
421,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
421,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
421,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
421,4,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
422,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
422,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
423,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
423,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
423,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
423,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
423,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
423,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
423,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
423,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
424,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
425,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
425,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
426,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
426,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
427,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
427,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
427,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
428,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
428,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
429,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
429,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
430,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
430,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
430,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
430,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
430,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
430,6,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
431,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
431,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
432,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
432,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
432,3,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
432,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
432,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
433,1,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
434,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
434,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
434,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
435,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
435,2,Artificial menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
435,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
435,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
435,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
435,6,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
435,7,Headache,Headaches NEC,Headaches,Nerv,N
435,8,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
435,9,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
435,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
435,11,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
435,12,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
435,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
435,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
435,15,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
435,16,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
436,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
436,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
437,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
438,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
439,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
439,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
440,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
441,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
442,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
443,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
443,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
444,1,Abnormal sleep-related event,Parasomnias,Sleep disorders and disturbances,Psych,N
444,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
444,3,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
444,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
444,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
444,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
444,7,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
444,8,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
444,9,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
444,10,Bone density increased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
444,11,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
444,12,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
444,13,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
444,14,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
444,15,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
444,16,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
444,17,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
444,18,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
444,19,Disorganised speech,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
444,20,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
444,21,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
444,22,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
444,23,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
444,24,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
444,25,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
444,26,Headache,Headaches NEC,Headaches,Nerv,N
444,27,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
444,28,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
444,29,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
444,30,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
444,31,Impaired reasoning,Thinking disturbances,Disturbances in thinking and perception,Psych,N
444,32,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
444,33,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
444,34,Myalgia,Muscle pains,Muscle disorders,Musc,N
444,35,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
444,36,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,37,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,38,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,39,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
444,40,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
444,41,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
444,42,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
444,43,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
444,44,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
444,45,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
444,46,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
444,47,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
444,48,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
444,49,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
444,50,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
444,51,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
444,52,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
444,53,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
445,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
445,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
445,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
445,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
445,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
446,1,Testis discomfort,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
447,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
448,1,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
449,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
449,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
449,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
449,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
449,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
449,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
449,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
449,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
450,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
450,2,Migraine,Migraine headaches,Headaches,Nerv,N
451,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
451,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
451,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
451,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
452,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
453,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
454,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
454,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
454,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
455,1,Headache,Headaches NEC,Headaches,Nerv,N
455,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
455,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
455,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
456,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
456,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
457,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
457,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
457,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
458,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
458,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
459,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
459,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
460,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
461,1,Bladder catheterisation,Therapeutic bladder catheterisation,Renal and urinary tract therapeutic procedures,Surg,N
461,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
461,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
462,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
462,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
462,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
462,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
463,1,Periprosthetic fracture,Musculoskeletal procedural complications,Procedural related injuries and complications NEC,Inj&P,N
464,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
464,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
464,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
464,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
464,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
465,1,Administration site mass,Administration site reactions NEC,Administration site reactions,Genrl,N
465,2,Administration site mass,Administration site reactions NEC,Administration site reactions,Genrl,N
465,3,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
465,4,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
465,5,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
465,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
465,7,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
465,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
465,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
465,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
465,11,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
465,12,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
465,13,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
465,14,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
465,15,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
465,16,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,17,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,18,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,19,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,20,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
465,21,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
465,22,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
466,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
466,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
466,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
466,4,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
467,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
468,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
469,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
470,1,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
470,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
471,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
471,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
471,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
472,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
472,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
472,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
472,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
472,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
473,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
473,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
473,3,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
473,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
473,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
473,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
473,7,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
473,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
473,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
473,10,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
473,11,Judgement impaired,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
473,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
473,13,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
473,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
473,15,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
473,16,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
473,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
473,18,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
474,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
475,1,Abscess soft tissue,Infections NEC,Infections - pathogen unspecified,Infec,N
475,2,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
476,1,Abulia,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
476,2,Acne,Acnes,Skin appendage conditions,Skin,N
476,3,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
476,4,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
476,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
476,6,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
476,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
476,8,Headache,Headaches NEC,Headaches,Nerv,N
476,9,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
476,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
476,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
476,12,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
476,13,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
476,14,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
477,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
477,2,Injection site fibrosis,Injection site reactions,Administration site reactions,Genrl,N
477,3,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
478,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
479,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
480,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
480,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
481,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
481,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
481,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
482,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
482,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
482,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
483,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
483,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
483,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
483,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
483,5,Visceral pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
484,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
484,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
484,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
484,4,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
484,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
484,6,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
484,7,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
484,8,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
484,9,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
484,10,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
484,11,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
484,12,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
484,13,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
484,14,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
484,15,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
484,16,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
484,17,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
484,18,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
484,19,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
484,20,Paramnesia,Amnestic symptoms,Dementia and amnestic conditions,Psych,N
484,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
484,22,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
484,23,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
484,24,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
485,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
485,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
485,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
485,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
485,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
485,6,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
486,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
487,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
487,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
487,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
488,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
488,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
488,4,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
489,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
489,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
489,3,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
489,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
489,5,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
489,6,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
490,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
491,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
492,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
492,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
492,3,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
492,4,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
492,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
492,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
492,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
492,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
493,1,Anal fissure,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
493,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
493,3,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
493,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
493,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
493,6,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
494,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
494,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
495,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
496,1,Penile pain,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
496,2,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
497,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
497,2,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
497,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
497,4,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
497,5,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
497,6,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
497,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
497,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
497,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
497,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
498,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
499,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
499,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
500,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
500,2,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
501,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
502,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
502,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
502,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
502,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
502,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
502,6,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
502,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
502,8,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
502,9,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
502,10,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
502,11,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
502,12,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
502,13,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
502,14,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
502,15,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
502,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
502,17,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
502,18,Headache,Headaches NEC,Headaches,Nerv,N
502,19,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
502,20,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
502,21,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
502,22,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
502,23,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
502,24,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
502,25,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
502,26,Migraine,Migraine headaches,Headaches,Nerv,N
502,27,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
502,28,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
502,29,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
502,30,Myalgia,Muscle pains,Muscle disorders,Musc,N
502,31,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
502,32,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
502,33,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
502,34,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
502,35,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
502,36,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
502,37,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
502,38,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
502,39,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
502,40,Stomach mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
502,41,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
502,42,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
502,43,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
503,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
503,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
503,3,Altered visual depth perception,Refractive and accommodative disorders,Vision disorders,Eye,N
503,4,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
503,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
503,6,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
503,7,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
503,8,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
503,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
503,10,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
503,11,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
503,12,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
503,13,Migraine,Migraine headaches,Headaches,Nerv,N
503,14,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
503,15,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
503,16,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
503,17,Sudden onset of sleep,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
503,18,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
503,19,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
503,20,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
503,21,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
503,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
504,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
504,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
504,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
504,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
504,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
504,6,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
504,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
504,8,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
504,9,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
504,10,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
504,11,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
504,12,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
504,13,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
504,14,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
504,15,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
504,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
504,17,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
504,18,Headache,Headaches NEC,Headaches,Nerv,N
504,19,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
504,20,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
504,21,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
504,22,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
504,23,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
504,24,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
504,25,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
504,26,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
504,27,Migraine,Migraine headaches,Headaches,Nerv,N
504,28,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
504,29,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
504,30,Muscle mass,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
504,31,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
504,32,Myalgia,Muscle pains,Muscle disorders,Musc,N
504,33,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
504,34,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
504,35,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
504,36,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
504,37,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
504,38,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
504,39,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
504,40,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
504,41,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
504,42,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
504,43,Stomach mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
504,44,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
504,45,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
504,46,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
504,47,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
505,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
505,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
506,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
506,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
506,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
506,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
506,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
506,6,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
507,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
507,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
508,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
508,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
509,1,Abdominal wall abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
510,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
510,2,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
511,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
511,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
511,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
511,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
512,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
513,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
513,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
513,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
514,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
514,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
515,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
515,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
515,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
515,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
515,5,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
515,6,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
515,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
515,8,Headache,Headaches NEC,Headaches,Nerv,N
515,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
515,10,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
515,11,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
515,12,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
515,13,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
515,14,Myalgia,Muscle pains,Muscle disorders,Musc,N
515,15,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
515,16,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
515,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
515,18,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
515,19,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
516,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
517,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
518,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
518,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
519,1,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
520,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
521,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
522,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
522,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
523,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
524,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
524,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
524,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
525,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
525,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
525,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
526,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
526,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
526,3,Headache,Headaches NEC,Headaches,Nerv,N
526,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
526,5,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
526,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
526,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,8,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
526,9,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
526,10,Urine flow decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
527,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
527,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
528,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
528,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
529,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
530,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
530,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
530,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
530,4,Non-alcoholic fatty liver,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
530,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
531,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
531,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
531,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
531,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
531,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
531,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
532,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
532,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
532,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
532,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
532,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
532,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
532,7,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
532,8,Headache,Headaches NEC,Headaches,Nerv,N
532,9,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
532,10,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
532,11,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
532,12,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
532,13,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
532,14,Migraine,Migraine headaches,Headaches,Nerv,N
532,15,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
532,16,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
532,17,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
532,18,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
532,19,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
532,20,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
532,21,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
532,22,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
532,23,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
533,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
533,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
534,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
535,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
535,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
535,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
536,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
537,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
538,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
538,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
538,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
538,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
538,5,Premenstrual dysphoric disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
538,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
539,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
540,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
541,1,Administration site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
541,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
542,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
543,1,Enthesopathy,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
543,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
543,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
544,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
544,2,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
545,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
546,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
547,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
547,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
547,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
547,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
548,1,Headache,Headaches NEC,Headaches,Nerv,N
548,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
549,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
550,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
550,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
550,3,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
551,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
551,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
551,3,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
551,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
551,5,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
551,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
551,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
551,8,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
551,9,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
551,10,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
551,11,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
551,12,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
551,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
551,14,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
552,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
552,2,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
552,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
552,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
553,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
553,2,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
553,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
553,4,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
553,5,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
553,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
553,7,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
553,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
553,9,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
553,10,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
553,11,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
553,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
553,13,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
553,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
553,15,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
553,16,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
553,17,Myalgia,Muscle pains,Muscle disorders,Musc,N
553,18,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
553,19,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
553,20,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
554,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
555,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
555,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
555,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
556,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
557,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
558,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
559,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
560,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
560,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
561,1,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
561,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
561,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
561,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
561,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
562,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
562,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
563,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
563,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
563,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
563,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
563,5,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
563,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
563,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
563,8,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
563,9,Headache,Headaches NEC,Headaches,Nerv,N
563,10,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
563,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
563,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
563,13,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
563,14,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
563,15,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
563,16,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
563,17,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
563,18,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
563,19,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
564,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
565,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
565,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
565,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
565,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
566,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
567,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
567,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
567,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
567,4,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
567,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
567,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
567,7,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
568,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
568,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
568,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
569,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
569,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
570,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
570,2,Enanthema,Mucosal findings abnormal,General system disorders NEC,Genrl,N
570,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
570,4,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
571,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
572,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
573,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
573,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
573,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
573,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
573,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
573,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
573,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
573,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
573,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
574,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
575,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
575,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
575,3,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
576,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
576,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
576,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
576,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
576,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
576,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
577,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
577,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
577,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
578,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
578,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
578,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
579,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
580,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
580,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
580,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
580,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
581,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
582,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
582,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
583,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
584,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
584,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
585,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
585,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
586,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
586,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
586,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
586,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
586,6,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
586,7,Spontaneous penile erection,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
586,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
587,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
588,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
589,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
590,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
591,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
591,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
591,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
592,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
592,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
592,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
592,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
592,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
592,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
593,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
594,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
595,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
596,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
597,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
597,2,Blood urea abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
597,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
597,4,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
597,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
597,6,Malignant transformation,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
597,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
597,8,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
597,9,Prostate cancer recurrent,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
597,10,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
598,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
598,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
598,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
599,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
600,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
600,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
600,3,Hand-eye coordination impaired,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
600,4,Illiteracy,Educational issues,Lifestyle issues,SocCi,N
600,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
601,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
601,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
601,3,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
602,1,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
602,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
602,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
603,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
603,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
603,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
604,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
604,2,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
604,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
604,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
604,5,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
604,6,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
604,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
605,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
605,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
605,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
605,4,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
605,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
605,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
605,7,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
605,8,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
605,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
606,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
607,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
607,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
607,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
607,4,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
607,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
608,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
608,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
608,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
608,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
608,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
608,6,Headache,Headaches NEC,Headaches,Nerv,N
608,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
608,8,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
609,1,Headache,Headaches NEC,Headaches,Nerv,N
609,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
609,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
609,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
609,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
610,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
610,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
610,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
610,4,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
611,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
611,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
612,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
612,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
612,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
613,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
614,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
614,2,Blood urea abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
614,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
614,4,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
614,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
614,6,Malignant transformation,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
614,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
614,8,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
614,9,Prostate cancer recurrent,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
614,10,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
615,1,Pregnancy test false positive,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
616,1,Pregnancy test false positive,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
617,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
617,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
618,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
619,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
620,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
621,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
621,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
621,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
621,4,Headache,Headaches NEC,Headaches,Nerv,N
621,5,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
621,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
621,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
621,8,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
622,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
622,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
622,3,Impaired reasoning,Thinking disturbances,Disturbances in thinking and perception,Psych,N
622,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
623,1,Headache,Headaches NEC,Headaches,Nerv,N
623,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
623,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
623,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
624,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
625,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
626,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
626,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
627,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
627,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
628,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
628,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
629,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
629,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
629,5,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,6,Headache,Headaches NEC,Headaches,Nerv,N
629,7,Migraine,Migraine headaches,Headaches,Nerv,N
629,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
629,9,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
629,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
629,11,Uterine pain,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
629,12,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
630,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
630,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
631,1,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
632,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
633,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
634,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
634,2,Headache,Headaches NEC,Headaches,Nerv,N
634,3,Migraine with aura,Migraine headaches,Headaches,Nerv,N
635,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
635,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
636,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
637,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
637,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
637,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
638,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
639,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
640,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
641,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
641,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
641,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
641,4,Body dysmorphic disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
641,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
641,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
641,7,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
641,8,Polycystic ovaries,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
641,9,Self-induced vomiting,Abnormal food elimination,Eating disorders and disturbances,Psych,N
642,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
643,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
644,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
645,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
646,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
646,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
647,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
647,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
647,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
648,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
649,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
650,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
651,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
652,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
653,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
653,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
653,3,Genital atrophy,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
653,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
653,5,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
654,1,Migraine,Migraine headaches,Headaches,Nerv,N
655,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
655,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
655,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
655,4,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
656,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
657,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
657,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
658,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
658,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
659,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
660,1,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
660,2,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
660,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
661,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
661,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
662,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
662,2,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
662,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
662,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
662,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
662,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
663,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
664,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
664,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
664,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
664,4,Premenstrual pain,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
665,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
665,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
665,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
665,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
666,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
666,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
666,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
666,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
666,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
666,6,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
667,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
667,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
668,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
669,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
670,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
671,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
672,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
672,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
672,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
672,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
673,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
673,2,Headache,Headaches NEC,Headaches,Nerv,N
673,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
674,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
674,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
674,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
674,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
675,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
675,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
675,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
675,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
675,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
676,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
676,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
677,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
678,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
678,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
679,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
680,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
680,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
680,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
681,1,Headache,Headaches NEC,Headaches,Nerv,N
681,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
682,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
683,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
683,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
683,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
684,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
684,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
684,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
685,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
685,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
685,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
686,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
687,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
687,2,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
688,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
688,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
689,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
690,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
690,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
690,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
691,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
692,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
692,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
693,1,Wrong patient,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
694,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
695,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
696,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
697,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
698,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
699,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
699,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
700,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
701,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
702,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
703,1,Headache,Headaches NEC,Headaches,Nerv,N
703,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
703,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
704,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
704,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
705,1,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
706,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
707,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
708,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
709,1,Prostatic specific antigen abnormal,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
710,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
711,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
711,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
712,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
713,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
713,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
714,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
715,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
715,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
716,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
716,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
717,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
718,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
718,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
718,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
718,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
718,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
718,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
718,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
718,8,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
718,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
718,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
718,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
719,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
719,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
719,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
719,4,Tic,Tic disorders,Changes in physical activity,Psych,N
720,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
720,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
720,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
721,1,Calcinosis,Trophic disorders,Tissue disorders NEC,Genrl,N
722,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
722,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
722,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
722,4,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
722,5,Headache,Headaches NEC,Headaches,Nerv,N
722,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
722,7,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
722,8,Migraine,Migraine headaches,Headaches,Nerv,N
722,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
722,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
722,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
722,12,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
722,13,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
722,14,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
722,15,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
723,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
723,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
724,1,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
725,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
726,1,Pituitary apoplexy,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
727,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
727,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
727,3,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
727,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
727,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
727,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
727,7,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
727,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
727,9,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
727,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
727,11,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
727,12,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
727,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
727,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
727,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
727,16,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
728,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
728,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
728,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
728,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
728,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
728,6,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
728,7,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
728,8,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
728,9,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
728,10,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
728,11,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
728,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
728,13,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
728,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
729,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
729,2,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
730,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
730,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
730,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
730,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
730,5,Headache,Headaches NEC,Headaches,Nerv,N
730,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
730,7,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
730,8,Madarosis,Alopecias,Skin appendage conditions,Skin,N
730,9,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
730,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
730,11,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
731,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
731,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
731,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
732,1,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
733,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
733,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
733,3,Migraine,Migraine headaches,Headaches,Nerv,N
733,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
733,5,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
733,6,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
733,7,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
733,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
734,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
735,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
736,1,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
737,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
738,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
738,2,Headache,Headaches NEC,Headaches,Nerv,N
738,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
738,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
739,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
740,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
742,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
743,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
744,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
744,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
745,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
745,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
746,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
747,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
748,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
